Theriva Biologics, Inc.
Ticker: 894158
values in millions
| Period | Q1 FY2026 |
|---|---|
| INCOME | |
| Revenue | 0.30 |
| Total Income | 0.30 |
| EXPENSES | |
| Expenditure | 2.43 |
| PROFIT | |
| PBT | -2.04 |
| Net Profit | -2.04 |
| KEY METRICS | |
| OPM % | -100.00% |
| NPM % | -100.00% |
| EPS | -0.05 |
Corporate Events
Board MeetingTOVX
20265Jun
Board Meeting
Special Meeting of Stockholders to seek approval for the iss…
SEC Filing ↗